DEA has said that for now it is extending emergency telehealth policies set during the COVID-19 pandemic, enabling certain health care providers to have greater leeway in prescribing some controlled substances.

FDA approved GSK’s respiratory syncytial virus (RSV) vaccine (Arexvy) for adults aged 60 years and older.

Findings from a University of Michigan national Poll on Healthy Aging suggest that older adults are supportive of the idea of deprescribing medications.

New findings from researchers at the National Institute of Allergy and Infectious Disease (NIAID) conclude that most children with Lyme disease recovered from their symptoms within 6 months.

Researchers of a new study reported that individuals infected with COVID-19 were significantly more likely to be diagnosed with type 2 diabetes within 1 year of their infection compared with those who had not been exposed to the virus. They also found that men were more likely than women to develop diabetes.